CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Operating activities
Net loss	$ (416,685)	$ (231,979)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	8,861	12,146
Realized gain on foreign currency adjustment		(146,255)
Provision for bad debts	217	684
Amortization of deferred financing costs included in interest expense	63	125
Deferred compensation	30,092	46,797
Compensation expense on stock-based arrangements with employees and consultants	51,478	57,915
Changes in operating assets and liabilities:
Accounts receivable	(8,011)	(6,591)
Inventories	(26,869)	31,515
Prepaid expenses and other current assets	(26,638)	(39,956)
Accounts payable	39,754	7,059
Accrued liabilities	28,248	12,683
Net cash used in operating activities	(319,490)	(255,857)
Investing activities
Purchases of property and equipment	(4,480)
Capitalized patent costs	(14,292)	(21,508)
Net cash used in investing activities	(18,772)	(21,508)
Financing activities
Additions to deferred financing costs		590
Proceeds from exercise of warrants		4,808
Proceeds from issuance of notes payable to stockholders	375,080	220,000
Proceeds from shareholder note receivable		34,535
Borrowings on capital lease		12,569
Payment of capital lease obligations	(1,799)	(1,423)
Net cash provided by financing activities	373,281	271,079
Net Increase (decrease) in cash and cash equivalents	35,019	(6,286)
Cash and cash equivalents at beginning of period	114,512	51,152
Cash and cash equivalents at end of period	149,531	44,866
Supplemental cash flow information:
Cash paid for interest	46,140	35,339
Common Stock issued in satisfaction of note payable	$ 150,000